| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |